Sex hormone-binding globulin as a biomarker for metabolic risk in European women with polycystic ovary syndrome

Objective Sex hormone-binding globulin (SHBG) is suggested to be a biomarker for metabolic disturbances in women with polycystic ovary syndrome (PCOS). Insulin resistance and hyperinsulinemia is common in PCOS patients. Low SHBG increases free testosterone levels, which further induces hyperinsuline...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Bo E. van Bree, Denise M. B. van der Heijden, Ron J. T. van Golde, Martijn C. G. J. Brouwers, Marc E. A. Spaanderman, Olivier Valkenburg
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2025-12-01
coleção:	Gynecological Endocrinology
Assuntos:	Polycystic ovary syndrome (PCOS) sex hormone-binding globulin (SHBG) metabolic phenotype metabolic syndrome hyperandrogenism
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/09513590.2025.2500462
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!